Lion Biotechnologies, Inc. — Form D

Lion Biotechnologies, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2016-06-15. The offering totals $100.0M, of which $100.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
Maria FardisDirectorSan Francisco, CA
Sanford J HillsbergDirectorLos Angeles, CA
Ryan J MaynardDirectorNew York, NY
Merrill McPeakDirectorNew York, NY
Wayne J RothbaumDirectorNew York, NY
Jay VenkatesanDirectorBoston, MA
Maria FardisExecutive OfficerSan Francisco, CA
Steven A FischkoffExecutive OfficerNew York, NY
Molly C HendersonExecutive OfficerNew York, NY
Michael T LotzeExecutive OfficerNew York, NY
Anthony CataldoDirectorBeverly Hills, CA
Anthony CataldoExecutive OfficerBeverly Hills, CA
Paul KesslerDirectorLos Angeles, CA
Merrill McPeakExecutive OfficerNew York, NY
Michael HandelmanDirectorBeverly Hills, CA
Michael HandelmanExecutive OfficerBeverly Hills, CA
Manish SinghDirectorFremont, CA
Manish SinghExecutive OfficerFremont, CA
Sanford HillsbergDirectorWOODLAND HILLS, CA
Mark J AhnDirectorPortland, OR
David VoytickyDirectorLos Angeles, CA
Merrill A McPeakDirectorKNOXVILLE, TN
Dr. L. Stephen ColesDirectorLOS ANGELES, CA
David A VoytickyDirectorLOS ANGELES, CA
Dr. William Stephen AndrewsDirectorLOS ANGELES, CA

Other filings by this issuer (7)

FiledFormOfferingSold
2013-11-15D$23.3M$23.3M
2013-06-06D$1.4M$1.4M
2011-08-09D$5.0M$5.0M
2011-05-03D$1.0M$500K
2011-01-21D$640K$640K
2010-11-08D$250K$250K
2010-10-01D$500K$500K

More